UK 00:11 Sunday, 25 October 2026
Breaking news and expert analysis on fast-moving AIM and LSE listed shares
How many times, over the years, has this company gone bust? I lose count. But at some stage surely folks should just say that a business model of selling not enough luxury cars to cover your costs and burning cash like it is going out of style is just bonkers. But I suppose that is how most big soccer clubs operate and when one owner runs out of dirty money another one comes along to shovel is cash into the furnace. Maybe Aston Martin Lagonda (AML) is a brand like Newcastle United and so normal maths do not matter. Today’s quarterlies are grim. Truly grim.
I must be getting old, but Halloween really does not interest me these days. Thank goodness today is the far more sensible All Saints’ Day. Meanwhile, from the perspective of the global financial markets, if the final day of October was somewhat busy, today and tomorrow are downright panic but there are three stocks to talk about today or, as I mildly amusingly put it, “the good, the great (but a bit expensive) and the ugly”.
I always analytically like the pharmaceutical sector, even if I am not enough of a sector geek to be a massive expert. It is getting close to two years since I bought GSK plc (GSK) shares for the first time in a couple of decades. It gave a solid Q3 set of numbers earlier today, talking about “2022 Guidance raised…(as it) expect to deliver growth in sales of between 8%-10% CER and growth in 2022 adjusted operating profit of between 15%-17% CER". It is always better to raise numbers than not, but that does not mean that the management, led by the extremely well remunerated Dame Emma, does not still have a bunch of questions to answer.
Did you watch the Dutch Grand Prix on TV yesterday? If you have been watching races this season, you will not be particularly surprised that it was another victory for Max Verstappen and the Red Bull team. Somewhat less successful, although they did get one point from a 10th place finish, was the Aston Martin Lagonda (AML) team, continuing its generally dull performance this year. There is always next year I guess. And at least the money will survive for the next year or two for the whole Aston Martin Lagonda business following the formal announcement today of a "fully committed and underwritten c.£575.8m Rights Issue...irrevocable commitments from PIF, the Yew Tree Consortium & Mercedes-Benz AG to take up their full entitlements, amounting to 44.7% of total Rights Issue". Such is the world of fast expensive cars and rich people.
